Mihaela Raicu
BIG-number: 89911297201
“Pathology is a team sport; sharing much with colleagues and endlessly learning from each other.”
Since April 2015, Mihaela Raicu (1981) has been working at the St. Antonius Hospital. In addition to general diagnostics, she has the ambition to further specialise in gynaecopathology, cytology, and gastrointestinal pathology. She studied Medicine at the University of Bucharest, Romania. After completing her studies (in 2007), she came to the Netherlands to do research to (in 2010) earn her PhD at the Cardiology department of the University Medical Centre Utrecht. The research was about the development of biomarkers for early detection of arteriosclerosis and unstable plaque. She did her Pathology training at the University Medical Centre Utrecht.
Fields of interest
- Gastrointestinal pathology
- Gynecopathology
- Pancreatic pathology
Publications
- Axial slicing versus bivalving in the pathological examination of pancreatoduodenectomy specimens (APOLLO): a multicentre randomized controlled trial
- Tumour-stroma ratio has poor prognostic value in nonpedunculated T1 colorectal cancer: A multicentre case-cohort study
- Microscopic resection margin status in pancreatic ductal adenocarcinoma – A nationwide analysis
- A novel cryoballoon ablation system for eradication of dysplastic Barrett's esophagus: a first-in-human feasibility study
- Efficacy of Dose-Escalated Chemoradiation on Complete Tumor Response in Patients with Locally Advanced Rectal Cancer (RECTAL-BOOST): A Phase 2 Randomized Controlled Trial
- Associations of non-pedunculated T1 colorectal adenocarcinoma outcome with consensus molecular subtypes, immunoscore, and microsatellite status: a multicenter case-cohort study.
- Detection, Treatment, and Survival of Pancreatic Cancer Recurrence in the Netherlands. A Nationwide Analysis
- First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II)
- Pubmed